<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04566900</url>
  </required_header>
  <id_info>
    <org_study_id>192022</org_study_id>
    <nct_id>NCT04566900</nct_id>
  </id_info>
  <brief_title>Neurofeedback to Improve Working Memory in Mild Cognitive Impairment</brief_title>
  <official_title>Enhancing Gamma Band Response in Mild Cognitive Impairment to Improve Working Memory</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mild cognitive impairment (MCI) has been identified as an early phase of Alzheimer's disease&#xD;
      (AD), a neurodegenerative disorder expected to affect 13.9 million Americans by 2060. AD&#xD;
      causes a progressive cognitive decline, including problems related to learning and memory,&#xD;
      that adversely affects life quality. Treatment intervention at the MCI stage of the disease&#xD;
      could potentially slow down the rate at which people may convert from MCI to AD. Increasing&#xD;
      evidence suggests that abnormal activity in frontal regions of the brain is associated with&#xD;
      cognitive deficits observed in AD. Furthermore, previous research has shown that&#xD;
      neurofeedback (NFB) training targeting these regions can improve memory, making it a&#xD;
      potential treatment for AD. NFB is a technique where an individual learns to change his/her&#xD;
      brain function in a particular direction, once that function has been made accessible through&#xD;
      a visual or auditory metaphor. We are proposing a novel, computer-based brain-training&#xD;
      program to enhance frontal gamma oscillatory activity in individuals with MCI. Results from&#xD;
      this study will build the scientific foundation necessary for larger clinical trials&#xD;
      dedicated to improving treatment options and outcomes for patients with MCI.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, double-blind, clinical trial to test the efficacy of&#xD;
      gamma-neurofeedback (G-NFB) compared to a placebo (P-NFB) in individuals with MCI. 112&#xD;
      consented participants will be randomized to receive G-NFB (n=56) or placebo-NFB (n=56)&#xD;
      during 30-45 minute sessions twice per week for 12 weeks (24 total sessions). Memory and&#xD;
      other cognitive domains will be measured using paper and pencil and computerized tests every&#xD;
      4 weeks during the study and at 4 weeks post completion of study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>MCI subjects will be assigned to active intervention or placebo.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Double-blind, randomized.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Working Memory accuracy</measure>
    <time_frame>From baseline to 12 weeks of treatment</time_frame>
    <description>Change in the computerized test, N-back will be used to measure working memory.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Durability of Change in Working Memory accuracy</measure>
    <time_frame>From baseline to 4weeks post end of study</time_frame>
    <description>Change in the computerized test, N-back will be used to measure working memory.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Gamma Band Response</measure>
    <time_frame>From baseline to 12 weeks of treatment</time_frame>
    <description>Change in Gamma oscillations will be measured while the subject performs the n-back task.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Durability of Gamma Band Response</measure>
    <time_frame>From baseline to 4weeks post end of study</time_frame>
    <description>Change in Gamma oscillations will be measured while the subject performs the n-back task.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Active Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be given a choice of videos consisting of still images set to music. Whether the video progresses and music continues to play will depend on the subject's ability to maintain frontal gamma oscillatory activity within a prespecified range. Over successive weeks, the parameters for positive feedback (music and video progression) will become incrementally more difficult.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Video and music progression will be random and will not depend on brain activity. Any progression will be by random chance alone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neurofeedback</intervention_name>
    <description>Neurofeedback is a technique where brain functions are made accessible to the subject in the form of a metaphor. For instance, frontal brain activity may be shown as an airplane flying. Once the activity is made accessible, the subject can modulate it in a pre-specified direction. The parameters used to achieve successful feedback are made difficult over time and hence the brain is taught or conditioned to improve performance.</description>
    <arm_group_label>Active Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Subjects in this arm will undergo all of the same testing as active treatment. Music and video progression will not depend on brain activity. Instead feedback will be random.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Meet criteria for mild cognitive impairment (MCI).&#xD;
&#xD;
          2. Living independently.&#xD;
&#xD;
          3. Literate in English.&#xD;
&#xD;
          4. Competent to participate in the informed consent process and provide voluntary&#xD;
             informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Frontal temporal dementia&#xD;
&#xD;
          2. Active alcohol or substance use disorder within the past year.&#xD;
&#xD;
          3. Brain cancer&#xD;
&#xD;
          4. Stroke within the last 2 years&#xD;
&#xD;
          5. Anti-epileptic medication&#xD;
&#xD;
          6. Prior head injury involving loss of consciousness&#xD;
&#xD;
          7. Seizure disorder&#xD;
&#xD;
          8. Use of medications likely to affect cognitive function (cf. donepezil, memantine). We&#xD;
             will not exclude for other medications but will examine their effects and include&#xD;
             medications as covariates as appropriate (e.g., presence v. absence; anticholinergic&#xD;
             load).&#xD;
&#xD;
          9. The potential benefits of the study do not outweigh the potential risks of the study,&#xD;
             as determined by the PI.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Veronica Gandara, B.S.</last_name>
    <phone>858-267-2257</phone>
    <email>vgandara@health.ucsd.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fiza Singh, M.D.</last_name>
    <email>fsingh@health.ucsd.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California at San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fiza Singh, MD</last_name>
      <phone>858-922-4365</phone>
      <email>fsingh@ucsd.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Diamond A. Executive functions. Annu Rev Psychol. 2013;64:135-68. doi: 10.1146/annurev-psych-113011-143750. Epub 2012 Sep 27. Review.</citation>
    <PMID>23020641</PMID>
  </reference>
  <reference>
    <citation>Döhnel K, Sommer M, Ibach B, Rothmayr C, Meinhardt J, Hajak G. Neural correlates of emotional working memory in patients with mild cognitive impairment. Neuropsychologia. 2008 Jan 15;46(1):37-48. Epub 2007 Aug 23.</citation>
    <PMID>17915264</PMID>
  </reference>
  <reference>
    <citation>Leuchter AF, Newton TF, Cook IA, Walter DO, Rosenberg-Thompson S, Lachenbruch PA. Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. Brain. 1992 Oct;115 ( Pt 5):1543-61.</citation>
    <PMID>1422803</PMID>
  </reference>
  <reference>
    <citation>Uhlhaas PJ, Singer W. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron. 2006 Oct 5;52(1):155-68. Review.</citation>
    <PMID>17015233</PMID>
  </reference>
  <reference>
    <citation>Stam CJ, van Cappellen van Walsum AM, Pijnenburg YA, Berendse HW, de Munck JC, Scheltens P, van Dijk BW. Generalized synchronization of MEG recordings in Alzheimer's Disease: evidence for involvement of the gamma band. J Clin Neurophysiol. 2002 Dec;19(6):562-74.</citation>
    <PMID>12488788</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>September 17, 2020</study_first_submitted>
  <study_first_submitted_qc>September 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2020</study_first_posted>
  <last_update_submitted>February 26, 2021</last_update_submitted>
  <last_update_submitted_qc>February 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Fiza Singh</investigator_full_name>
    <investigator_title>Associate Professor of Psychiatry</investigator_title>
  </responsible_party>
  <keyword>neurofeedback</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

